Intrinsic value of Allscripts Healthcare Solutions - MDRX

Previous Close

$13.83

  Intrinsic Value

$24.11

stock screener

  Rating & Target

str. buy

+74%

Previous close

$13.83

 
Intrinsic value

$24.11

 
Up/down potential

+74%

 
Rating

str. buy

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of MDRX stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  11.83
  14.50
  13.55
  12.70
  11.93
  11.23
  10.61
  10.05
  9.54
  9.09
  8.68
  8.31
  7.98
  7.68
  7.41
  7.17
  6.96
  6.76
  6.58
  6.43
  6.28
  6.15
  6.04
  5.94
  5.84
  5.76
  5.68
  5.61
  5.55
  5.50
  5.45
Revenue, $m
  1,550
  1,775
  2,015
  2,271
  2,542
  2,827
  3,127
  3,442
  3,770
  4,113
  4,470
  4,841
  5,228
  5,629
  6,047
  6,481
  6,931
  7,400
  7,887
  8,394
  8,921
  9,471
  10,043
  10,639
  11,260
  11,908
  12,585
  13,292
  14,030
  14,801
  15,607
Variable operating expenses, $m
 
  1,433
  1,601
  1,780
  1,969
  2,168
  2,378
  2,598
  2,827
  3,067
  3,316
  3,384
  3,654
  3,934
  4,226
  4,529
  4,844
  5,172
  5,512
  5,866
  6,235
  6,619
  7,018
  7,435
  7,869
  8,323
  8,795
  9,289
  9,805
  10,344
  10,907
Fixed operating expenses, $m
 
  224
  230
  236
  242
  248
  254
  260
  267
  274
  280
  287
  295
  302
  309
  317
  325
  333
  342
  350
  359
  368
  377
  386
  396
  406
  416
  427
  437
  448
  459
Total operating expenses, $m
  1,490
  1,657
  1,831
  2,016
  2,211
  2,416
  2,632
  2,858
  3,094
  3,341
  3,596
  3,671
  3,949
  4,236
  4,535
  4,846
  5,169
  5,505
  5,854
  6,216
  6,594
  6,987
  7,395
  7,821
  8,265
  8,729
  9,211
  9,716
  10,242
  10,792
  11,366
Operating income, $m
  60
  118
  184
  256
  331
  411
  495
  584
  676
  773
  873
  1,171
  1,280
  1,393
  1,511
  1,634
  1,762
  1,895
  2,034
  2,178
  2,328
  2,484
  2,647
  2,817
  2,995
  3,180
  3,374
  3,576
  3,788
  4,009
  4,240
EBITDA, $m
  232
  377
  453
  534
  619
  710
  806
  906
  1,011
  1,120
  1,234
  1,353
  1,477
  1,605
  1,739
  1,879
  2,023
  2,174
  2,331
  2,494
  2,664
  2,841
  3,026
  3,218
  3,419
  3,629
  3,848
  4,077
  4,316
  4,567
  4,828
Interest expense (income), $m
  42
  56
  72
  89
  108
  127
  147
  169
  191
  215
  239
  265
  291
  319
  347
  377
  408
  440
  474
  509
  545
  582
  622
  662
  705
  749
  796
  844
  894
  947
  1,002
Earnings before tax, $m
  -15
  61
  112
  166
  224
  284
  348
  415
  485
  558
  634
  906
  989
  1,075
  1,164
  1,257
  1,354
  1,455
  1,560
  1,669
  1,783
  1,902
  2,026
  2,155
  2,290
  2,431
  2,578
  2,732
  2,893
  3,062
  3,238
Tax expense, $m
  -18
  17
  30
  45
  60
  77
  94
  112
  131
  151
  171
  245
  267
  290
  314
  339
  366
  393
  421
  451
  481
  513
  547
  582
  618
  656
  696
  738
  781
  827
  874
Net income, $m
  3
  45
  82
  121
  163
  208
  254
  303
  354
  407
  463
  661
  722
  784
  850
  918
  988
  1,062
  1,139
  1,218
  1,302
  1,388
  1,479
  1,573
  1,671
  1,774
  1,882
  1,994
  2,112
  2,235
  2,364

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  97
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  3,832
  4,277
  4,856
  5,472
  6,125
  6,813
  7,536
  8,293
  9,085
  9,910
  10,771
  11,666
  12,597
  13,565
  14,571
  15,616
  16,702
  17,831
  19,005
  20,227
  21,498
  22,821
  24,199
  25,635
  27,133
  28,695
  30,326
  32,028
  33,806
  35,665
  37,608
Adjusted assets (=assets-cash), $m
  3,735
  4,277
  4,856
  5,472
  6,125
  6,813
  7,536
  8,293
  9,085
  9,910
  10,771
  11,666
  12,597
  13,565
  14,571
  15,616
  16,702
  17,831
  19,005
  20,227
  21,498
  22,821
  24,199
  25,635
  27,133
  28,695
  30,326
  32,028
  33,806
  35,665
  37,608
Revenue / Adjusted assets
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
  0.415
Average production assets, $m
  806
  923
  1,048
  1,181
  1,322
  1,470
  1,626
  1,790
  1,960
  2,139
  2,324
  2,518
  2,718
  2,927
  3,144
  3,370
  3,604
  3,848
  4,101
  4,365
  4,639
  4,925
  5,222
  5,532
  5,855
  6,192
  6,544
  6,912
  7,295
  7,696
  8,116
Working capital, $m
  -63
  -153
  -173
  -195
  -219
  -243
  -269
  -296
  -324
  -354
  -384
  -416
  -450
  -484
  -520
  -557
  -596
  -636
  -678
  -722
  -767
  -814
  -864
  -915
  -968
  -1,024
  -1,082
  -1,143
  -1,207
  -1,273
  -1,342
Total debt, $m
  1,331
  1,678
  2,077
  2,502
  2,951
  3,425
  3,923
  4,445
  4,990
  5,559
  6,152
  6,769
  7,410
  8,077
  8,770
  9,490
  10,239
  11,017
  11,826
  12,667
  13,543
  14,454
  15,404
  16,394
  17,426
  18,502
  19,625
  20,798
  22,024
  23,304
  24,643
Total liabilities, $m
  2,600
  2,947
  3,346
  3,771
  4,220
  4,694
  5,192
  5,714
  6,259
  6,828
  7,421
  8,038
  8,679
  9,346
  10,039
  10,759
  11,508
  12,286
  13,095
  13,936
  14,812
  15,723
  16,673
  17,663
  18,695
  19,771
  20,894
  22,067
  23,293
  24,573
  25,912
Total equity, $m
  1,232
  1,330
  1,510
  1,702
  1,905
  2,119
  2,344
  2,579
  2,825
  3,082
  3,350
  3,628
  3,918
  4,219
  4,531
  4,857
  5,194
  5,546
  5,911
  6,290
  6,686
  7,097
  7,526
  7,973
  8,438
  8,924
  9,431
  9,961
  10,514
  11,092
  11,696
Total liabilities and equity, $m
  3,832
  4,277
  4,856
  5,473
  6,125
  6,813
  7,536
  8,293
  9,084
  9,910
  10,771
  11,666
  12,597
  13,565
  14,570
  15,616
  16,702
  17,832
  19,006
  20,226
  21,498
  22,820
  24,199
  25,636
  27,133
  28,695
  30,325
  32,028
  33,807
  35,665
  37,608
Debt-to-equity ratio
  1.080
  1.260
  1.380
  1.470
  1.550
  1.620
  1.670
  1.720
  1.770
  1.800
  1.840
  1.870
  1.890
  1.910
  1.940
  1.950
  1.970
  1.990
  2.000
  2.010
  2.030
  2.040
  2.050
  2.060
  2.070
  2.070
  2.080
  2.090
  2.090
  2.100
  2.110
Adjusted equity ratio
  0.304
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311
  0.311

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  3
  45
  82
  121
  163
  208
  254
  303
  354
  407
  463
  661
  722
  784
  850
  918
  988
  1,062
  1,139
  1,218
  1,302
  1,388
  1,479
  1,573
  1,671
  1,774
  1,882
  1,994
  2,112
  2,235
  2,364
Depreciation, amort., depletion, $m
  172
  259
  268
  278
  288
  299
  310
  322
  334
  347
  361
  182
  197
  212
  228
  244
  261
  279
  297
  316
  336
  357
  378
  401
  424
  449
  474
  501
  529
  558
  588
Funds from operations, $m
  323
  304
  350
  399
  452
  507
  564
  625
  688
  755
  824
  844
  919
  997
  1,078
  1,162
  1,250
  1,341
  1,436
  1,535
  1,638
  1,745
  1,857
  1,974
  2,096
  2,223
  2,356
  2,495
  2,641
  2,793
  2,952
Change in working capital, $m
  54
  -19
  -21
  -22
  -23
  -25
  -26
  -27
  -28
  -29
  -31
  -32
  -33
  -35
  -36
  -37
  -39
  -40
  -42
  -44
  -45
  -47
  -49
  -51
  -53
  -56
  -58
  -61
  -63
  -66
  -69
Cash from operations, $m
  269
  323
  371
  421
  475
  531
  590
  652
  717
  784
  855
  876
  952
  1,031
  1,114
  1,199
  1,288
  1,381
  1,478
  1,578
  1,683
  1,792
  1,906
  2,025
  2,149
  2,279
  2,414
  2,556
  2,704
  2,859
  3,021
Maintenance CAPEX, $m
  0
  -58
  -67
  -76
  -86
  -96
  -107
  -118
  -130
  -142
  -155
  -168
  -182
  -197
  -212
  -228
  -244
  -261
  -279
  -297
  -316
  -336
  -357
  -378
  -401
  -424
  -449
  -474
  -501
  -529
  -558
New CAPEX, $m
  -138
  -117
  -125
  -133
  -141
  -148
  -156
  -163
  -171
  -178
  -186
  -193
  -201
  -209
  -217
  -226
  -234
  -244
  -253
  -264
  -274
  -286
  -297
  -310
  -323
  -337
  -352
  -367
  -384
  -401
  -419
Cash from investing activities, $m
  -1,154
  -175
  -192
  -209
  -227
  -244
  -263
  -281
  -301
  -320
  -341
  -361
  -383
  -406
  -429
  -454
  -478
  -505
  -532
  -561
  -590
  -622
  -654
  -688
  -724
  -761
  -801
  -841
  -885
  -930
  -977
Free cash flow, $m
  -885
  148
  179
  212
  248
  287
  328
  371
  416
  464
  514
  514
  569
  625
  684
  746
  810
  876
  946
  1,018
  1,093
  1,171
  1,252
  1,337
  1,425
  1,517
  1,614
  1,714
  1,820
  1,929
  2,044
Issuance/(repayment) of debt, $m
  660
  374
  399
  425
  450
  474
  498
  522
  545
  569
  593
  617
  642
  667
  693
  720
  748
  778
  809
  841
  876
  912
  950
  990
  1,032
  1,076
  1,123
  1,173
  1,225
  1,280
  1,339
Issuance/(repurchase) of shares, $m
  212
  123
  98
  70
  40
  6
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  865
  497
  497
  495
  490
  480
  498
  522
  545
  569
  593
  617
  642
  667
  693
  720
  748
  778
  809
  841
  876
  912
  950
  990
  1,032
  1,076
  1,123
  1,173
  1,225
  1,280
  1,339
Total cash flow (excl. dividends), $m
  -20
  645
  677
  707
  738
  767
  826
  893
  962
  1,033
  1,107
  1,131
  1,210
  1,292
  1,377
  1,466
  1,558
  1,654
  1,754
  1,859
  1,968
  2,082
  2,202
  2,326
  2,457
  2,594
  2,737
  2,887
  3,045
  3,210
  3,383
Retained Cash Flow (-), $m
  176
  -168
  -180
  -192
  -203
  -214
  -225
  -236
  -246
  -257
  -268
  -278
  -290
  -301
  -313
  -325
  -338
  -351
  -365
  -380
  -395
  -412
  -429
  -447
  -466
  -486
  -507
  -529
  -553
  -578
  -604
Prev. year cash balance distribution, $m
 
  70
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  547
  496
  516
  535
  553
  601
  657
  715
  776
  839
  853
  921
  991
  1,065
  1,141
  1,220
  1,303
  1,389
  1,479
  1,573
  1,671
  1,773
  1,880
  1,991
  2,108
  2,230
  2,358
  2,492
  2,632
  2,779
Discount rate, %
 
  8.00
  8.40
  8.82
  9.26
  9.72
  10.21
  10.72
  11.26
  11.82
  12.41
  13.03
  13.68
  14.37
  15.09
  15.84
  16.63
  17.46
  18.34
  19.25
  20.22
  21.23
  22.29
  23.40
  24.57
  25.80
  27.09
  28.45
  29.87
  31.36
  32.93
PV of cash for distribution, $m
 
  506
  422
  400
  375
  348
  335
  322
  305
  284
  260
  222
  198
  173
  149
  126
  104
  84
  67
  52
  40
  29
  21
  15
  10
  7
  4
  3
  2
  1
  1
Current shareholders' claim on cash, %
  100
  95.0
  91.7
  89.6
  88.6
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5
  88.5

Allscripts Healthcare Solutions, Inc. (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions. The Population Health segment includes the sale of health management and coordinated care solutions, which focus on hospitals, health systems, other care facilities and accountable care organizations (ACOs). The Netsmart segment provides software and technology solutions to the health and human services industry, which includes behavioral health, addiction treatment, intellectual and developmental disability services, child and family services and public health segments, as well as to post-acute home care organizations.

FINANCIAL RATIOS  of  Allscripts Healthcare Solutions (MDRX)

Valuation Ratios
P/E Ratio 832.2
Price to Sales 1.6
Price to Book 2
Price to Tangible Book
Price to Cash Flow 9.3
Price to Free Cash Flow 19.1
Growth Rates
Sales Growth Rate 11.8%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 102.9%
Cap. Spend. - 3 Yr. Gr. Rate 3.5%
Financial Strength
Quick Ratio 4
Current Ratio 0
LT Debt to Equity 105.8%
Total Debt to Equity 108%
Interest Coverage 1
Management Effectiveness
Return On Assets -0.2%
Ret/ On Assets - 3 Yr. Avg. -1.2%
Return On Total Capital 0.1%
Ret/ On T. Cap. - 3 Yr. Avg. -1.2%
Return On Equity 0.2%
Return On Equity - 3 Yr. Avg. -1.7%
Asset Turnover 0.5
Profitability Ratios
Gross Margin 43.3%
Gross Margin - 3 Yr. Avg. 41.6%
EBITDA Margin 12.8%
EBITDA Margin - 3 Yr. Avg. 11.5%
Operating Margin 3.9%
Oper. Margin - 3 Yr. Avg. 1.1%
Pre-Tax Margin -1%
Pre-Tax Margin - 3 Yr. Avg. -1.9%
Net Profit Margin 0.2%
Net Profit Margin - 3 Yr. Avg. -1.6%
Effective Tax Rate 120%
Eff/ Tax Rate - 3 Yr. Avg. 141%
Payout Ratio 0%

MDRX stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the MDRX stock intrinsic value calculation we used $1550 million for the last fiscal year's total revenue generated by Allscripts Healthcare Solutions. The default revenue input number comes from 2016 income statement of Allscripts Healthcare Solutions. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our MDRX stock valuation model: a) initial revenue growth rate of 14.5% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 8%, whose default value for MDRX is calculated based on our internal credit rating of Allscripts Healthcare Solutions, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Allscripts Healthcare Solutions.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of MDRX stock the variable cost ratio is equal to 82.3%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $219 million in the base year in the intrinsic value calculation for MDRX stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 4.3% for Allscripts Healthcare Solutions.

Corporate tax rate of 27% is the nominal tax rate for Allscripts Healthcare Solutions. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the MDRX stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for MDRX are equal to 52%.

Life of production assets of 13.8 years is the average useful life of capital assets used in Allscripts Healthcare Solutions operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for MDRX is equal to -8.6%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $1232 million for Allscripts Healthcare Solutions - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 180.756 million for Allscripts Healthcare Solutions is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Allscripts Healthcare Solutions at the current share price and the inputted number of shares is $2.5 billion.

RELATED COMPANIES Price Int.Val. Rating
CERN Cerner 64.22 37.86  sell
QSII Quality System 12.69 3.99  str.sell
CPSI Computer Progr 31.30 21.77  sell
UNH UnitedHealth G 229.37 191.21  hold
STRM Streamline Hea 1.73 0.06  str.sell
NH NantHealth 3.29 0.67  str.sell
MMM 3M 236.67 160.70  sell
MCK McKesson 150.50 1,204.99  str.buy
ATHN athenahealth 138.82 32.55  str.sell

COMPANY NEWS

▶ AllScripts meets 4Q profit forecasts   [04:27PM  Associated Press]
▶ Allscripts Names Dennis Olis Chief Financial Officer   [Jan-31-18 04:01PM  GlobeNewswire]
▶ Allscripts to acquire Practice Fusion business   [Jan-08-18 08:01AM  GlobeNewswire]
▶ Allscripts to attend upcoming investor events   [Dec-04-17 04:01PM  GlobeNewswire]
▶ Gippsland Health Alliance selects Allscripts EMR   [Nov-06-17 04:01PM  GlobeNewswire]
▶ AllScripts reports 3Q loss   [Nov-02-17 05:26PM  Associated Press]
▶ Allscripts appoints Gaylene Ray   [Oct-05-17 04:30PM  GlobeNewswire]
▶ Stocks Showing Improved Relative Strength: Allscripts Healthcare Solutions   [Sep-12-17 03:00AM  Investor's Business Daily]
▶ Allscripts to hold meeting for investors on August 8   [Aug-07-17 04:01PM  GlobeNewswire]
▶ AllScripts reports 2Q loss   [02:32AM  Associated Press]
▶ Allscripts announces second quarter 2017 results   [Aug-03-17 04:04PM  GlobeNewswire]
Financial statements of MDRX
Follow us on:   twitter   twitter   twitter   twitter

ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.